(28)The primary focus of the strategic European investment window should be on support to those final recipients established in a Member State and operating in the Union whose activities are of strategic importance to the Union in particular in view of the green and digital transitions and of enhanced resilience in areas of (i) critical healthcare provision, manufacturing and stockpiling of pharmaceuticals, medical devices and medical supplies, strengthening of health crisis response capacity and of the civil protection system, (ii) critical infrastructure, whether physical or virtual; (iii) provision of goods and services instrumental to the operation and maintenance of such infrastructure, (iv) key enabling, transformative, green and digital technologies and game-changing innovations where the investment is strategically important for the Union's industrial future, including artificial intelligence, blockchain, software, robotics, semiconductors, microprocessors, edge cloud technologies, high-performance computing, cybersecurity, quantum technologies, photonics, industrial biotechnology, renewable energy technologies, energy storage technologies including batteries, sustainable transport technologies, clean hydrogen and fuel cell applications, decarbonisation technologies for industry, carbon capture and storage, circular economy technologies biomedicine, nanotechnologies, pharmaceuticals and advanced materials; (v) manufacturing facilities for mass production of Information Communication and Technology components and devices in the EU; (vi) supply and stockpiling of critical inputs to public actors, businesses or consumers in the Union; (vii) critical technologies and inputs for the security of the Union and its Member States, such as defence and space sectors and cybersecurity, and dual use items as defined in point 1 of Article 2 of Council Regulation (EC) No 428/2009.
(28)Primarni poudarek sklopa za strateške evropske naložbe bi moral biti na podpori končnim prejemnikom, ki imajo sedež v državi članici in delujejo v Uniji ter katerih dejavnosti so strateškega pomena za Unijo, zlasti za zeleni in digitalni prehod ter krepitev odpornosti na področju (i) zagotavljanja kritičnih zdravstvenih storitev, proizvodnje in skladiščenja farmacevtskih izdelkov, medicinskih pripomočkov in medicinske opreme, krepitve zmogljivosti za odzivanje na zdravstvene krize in sistema civilne zaščite; (ii) kritične infrastrukture, tako fizične kot virtualne; (iii) zagotavljanja blaga in storitev, bistvenih za delovanje in vzdrževanje take infrastrukture; (iv) ključnih omogočitvenih, preobrazbenih, zelenih in digitalnih tehnologij ter prelomnih inovacij, kadar so naložbe strateškega pomena za industrijsko prihodnost Unije, vključno z umetno inteligenco, blokovno verigo, programsko opremo, robotiko, polprevodniki, mikroprocesorji, tehnologijami oblaka na robu, visokozmogljivostnim računalništvom, kibernetsko varnostjo, kvantnimi tehnologijami, fotoniko, industrijsko biotehnologijo, tehnologijami energije iz obnovljivih virov, tehnologijami shranjevanja energije, vključno z baterijami, trajnostnimi prometnimi tehnologijami, čistim vodikom in gorivnimi celicami, tehnologijami za razogljičenje za industrijo, zajemanjem in shranjevanjem ogljika, tehnologijami krožnega gospodarstva, biomedicino, nanotehnologijami, farmacevtskimi izdelki in naprednimi materiali; (v) proizvodnih obratov za serijsko proizvodnjo sestavnih delov in naprav informacijske in komunikacijske tehnologije v EU; (vi) dobave in skladiščenja kritičnih virov za javne akterje, podjetja ali potrošnike v Uniji; (vii) kritičnih tehnologij in virov za varnost Unije in njenih držav članic (npr. obrambni in vesoljski sektor ter kibernetska varnost) ter blaga z dvojno rabo, kot je opredeljeno v točki (1) člena 2 Uredbe Sveta (ES) št. 428/2009.